Medical insurance drug traceability supervision method and system based on identifier analysis and block chain

Abstract

The invention discloses a medical insurance drug traceability supervision method and system based on identification analysis and a block chain, and belongs to the field of drug supervision. The method comprises the following specific steps: S1, coding the rest part of a medicine identification prefix according to production requirements; s2, performing block chain encryption on production and circulation data of the medical insurance drugs; s3, medicine production and circulation information is inquired through the traceability and supervision platform, and traceability and supervision of the medical insurance medicine are carried out; by means of the characteristics of distributed data storage, point-to-point transmission, a consensus mechanism and the like of the block chain, technologies such as credible data collection, data portraying, medicine tracing and the like of medical insurance medicine circulation supervision are researched, a medical insurance medicine tracing and supervision platform based on the block chain is researched and developed, data interconnection and intercommunication in the medical insurance medicine production and circulation process are achieved, and the medical insurance medicine tracing and supervision efficiency is improved. The system assists drug manufacturers, operators, drugstore retail, hospitals and consumers in tracing, provides credible data support for medical insurance drug tracing and supervision, and guarantees the safety of medical insurance funds.

Description

technical field [0001] The invention discloses a medical insurance drug traceability supervision method and system based on identification analysis and blockchain, and relates to the technical field of drug supervision. Background technique [0002] At present, my country has established a relatively complete medical security system. According to statistics from the National Medical Security Bureau, as of 2020, 1.361 billion people have been covered by basic medical insurance nationwide, and the insurance coverage rate has stabilized at more than 95%. Due to their low prices, medical insurance drugs have become the targets of lawbreakers. There are serious phenomena such as prescribing false prescriptions without illnesses, multiple prescriptions for illnesses, "cross-selling", backflow medicines, and drug arbitrage. The production and distribution of medicines involves pharmaceutical factories, hospitals, and pharmacies. , consumers and other links, the long supply chain of...

AI Technical Summary

Problems solved by technology

Medical insurance drugs have become the targets of lawbreakers because of their low prices. There are serious phenomena such as prescribing false prescriptions without illnesses, multiple prescriptions for patients with illnesses, "cross-selling", backflow medicines, and drug arbitrage. The production and distribution of medicines involves pharmaceutical factories, hospitals, and pharmacies. , consumers and other links, the long supply chain of the pharmaceutical industry and the large geographical span have led to difficulties in the supervision of medical insurance drugs

Although pharmaceutical manufacturers, wholesalers, and pharmacies have established corresponding information systems to assist drug traceability supply chain management, each system is relatively isolated and data sharing is difficult, and the credibility of the data has also been questioned by the public

Images